Alkermes to Take Part in Stifel's 3rd Annual CNS Day
Get Alerts ALKS Hot Sheet
Join SI Premium – FREE
DUBLIN, March 25, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at Stifel's 3rd Annual CNS Day on Thursday, Apr. 1, 2021 at 8:30 a.m. ET (1:30 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Contact:Alex BraunInvestor Relations+1 781 296 8493
View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-stifels-3rd-annual-cns-day-301256281.html
SOURCE Alkermes plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
- GWM Holds Global Press Conference, Demonstrating Determination to Develop Globally
- Gravity Announces Filing of Annual Report on Form 20-F for Fiscal Year 2023
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!